124 related articles for article (PubMed ID: 25898179)
1. Glutamate-Mediated Down-Regulation of the Multidrug-Resistance Protein BCRP/ABCG2 in Porcine and Human Brain Capillaries.
Salvamoser JD; Avemary J; Luna-Munguia H; Pascher B; Getzinger T; Pieper T; Kudernatsch M; Kluger G; Potschka H
Mol Pharm; 2015 Jun; 12(6):2049-60. PubMed ID: 25898179
[TBL] [Abstract][Full Text] [Related]
2. Glutamate-mediated upregulation of the multidrug resistance protein 2 in porcine and human brain capillaries.
Luna-Munguia H; Salvamoser JD; Pascher B; Pieper T; Getzinger T; Kudernatsch M; Kluger G; Potschka H
J Pharmacol Exp Ther; 2015 Feb; 352(2):368-78. PubMed ID: 25503388
[TBL] [Abstract][Full Text] [Related]
3. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
Hoque MT; Shah A; More V; Miller DS; Bendayan R
J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
[TBL] [Abstract][Full Text] [Related]
4. BCRP at the blood-brain barrier: genomic regulation by 17β-estradiol.
Mahringer A; Fricker G
Mol Pharm; 2010 Oct; 7(5):1835-47. PubMed ID: 20735085
[TBL] [Abstract][Full Text] [Related]
5. Seizure-induced up-regulation of P-glycoprotein at the blood-brain barrier through glutamate and cyclooxygenase-2 signaling.
Bauer B; Hartz AM; Pekcec A; Toellner K; Miller DS; Potschka H
Mol Pharmacol; 2008 May; 73(5):1444-53. PubMed ID: 18094072
[TBL] [Abstract][Full Text] [Related]
6. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation.
Yousif S; Chaves C; Potin S; Margaill I; Scherrmann JM; Declèves X
J Neurochem; 2012 Nov; 123(4):491-503. PubMed ID: 22845665
[TBL] [Abstract][Full Text] [Related]
7. Prevention of seizure-induced up-regulation of endothelial P-glycoprotein by COX-2 inhibition.
Zibell G; Unkrüer B; Pekcec A; Hartz AM; Bauer B; Miller DS; Potschka H
Neuropharmacology; 2009 Apr; 56(5):849-55. PubMed ID: 19371577
[TBL] [Abstract][Full Text] [Related]
8. Dynamic regulation of P-glycoprotein in human brain capillaries.
Avemary J; Salvamoser JD; Peraud A; Rémi J; Noachtar S; Fricker G; Potschka H
Mol Pharm; 2013 Sep; 10(9):3333-41. PubMed ID: 23924183
[TBL] [Abstract][Full Text] [Related]
9. Valproic Acid-Induced Upregulation of Multidrug Efflux Transporter ABCG2/BCRP via PPAR
Kukal S; Bora S; Kanojia N; Singh P; Paul PR; Rawat C; Sagar S; Bhatraju NK; Grewal GK; Singh A; Kukreti S; Satyamoorthy K; Kukreti R
Mol Pharmacol; 2023 Mar; 103(3):145-157. PubMed ID: 36414374
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor beta signaling through phosphatase and tensin homolog/phosphoinositide 3-kinase/Akt/glycogen synthase kinase 3 down-regulates blood-brain barrier breast cancer resistance protein.
Hartz AM; Madole EK; Miller DS; Bauer B
J Pharmacol Exp Ther; 2010 Aug; 334(2):467-76. PubMed ID: 20460386
[TBL] [Abstract][Full Text] [Related]
11. 17-β-Estradiol: a powerful modulator of blood-brain barrier BCRP activity.
Hartz AM; Mahringer A; Miller DS; Bauer B
J Cereb Blood Flow Metab; 2010 Oct; 30(10):1742-55. PubMed ID: 20216549
[TBL] [Abstract][Full Text] [Related]
12. The xenoestrogens ethinylestradiol and bisphenol A regulate BCRP at the blood-brain barrier of rats.
Nickel S; Mahringer A
Xenobiotica; 2014 Nov; 44(11):1046-54. PubMed ID: 24945792
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Determination of Luminal and Abluminal Membrane Distributions of Transporters in Porcine Brain Capillaries by Plasma Membrane Fractionation and Quantitative Targeted Proteomics.
Kubo Y; Ohtsuki S; Uchida Y; Terasaki T
J Pharm Sci; 2015 Sep; 104(9):3060-8. PubMed ID: 25703048
[TBL] [Abstract][Full Text] [Related]
14. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.
Sakata S; Fujiwara M; Ohtsuka K; Kamma H; Nagane M; Sakamoto A; Fujioka Y
Oncol Rep; 2011 Feb; 25(2):333-9. PubMed ID: 21165575
[TBL] [Abstract][Full Text] [Related]
15. Investigation of efflux transport of dehydroepiandrosterone sulfate and mitoxantrone at the mouse blood-brain barrier: a minor role of breast cancer resistance protein.
Lee YJ; Kusuhara H; Jonker JW; Schinkel AH; Sugiyama Y
J Pharmacol Exp Ther; 2005 Jan; 312(1):44-52. PubMed ID: 15448171
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
Doyle L; Ross DD
Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
[TBL] [Abstract][Full Text] [Related]
17. Impact of breast cancer resistance protein on cancer treatment outcomes.
Ross DD; Nakanishi T
Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
[TBL] [Abstract][Full Text] [Related]
18. Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain.
Aronica E; Gorter JA; Redeker S; van Vliet EA; Ramkema M; Scheffer GL; Scheper RJ; van der Valk P; Leenstra S; Baayen JC; Spliet WG; Troost D
Epilepsia; 2005 Jun; 46(6):849-57. PubMed ID: 15946326
[TBL] [Abstract][Full Text] [Related]
19. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
Römermann K; Helmer R; Löscher W
Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
[TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
